Sunday, February 17, 2013

State policies on Medicaid committee disclosure vary

By Andrew M. Seaman NEW YORK (Reuters Health) – No standard policy covers whether the state-level Medicaid committee members choosing which drugs and treatments the program pays for should disclose their ties to drug and medical device companies, according to a new report. Health policy...
State policies on Medicaid committee disclosure vary